Remission InductionRemission, SpontaneousCytarabineAsparaginaseDaunorubicinPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, Acute6-MercaptopurineVincristineAntineoplastic Combined Chemotherapy ProtocolsMethotrexateThioguanineIdarubicinTreatment OutcomeLeukemia, MyeloidPrednisoneRecurrenceLeukemia, LymphoidCyclophosphamideAcute DiseasePrognosisDisease-Free SurvivalNeoplasm, ResidualLeukemia, Promyelocytic, AcuteBone MarrowLeukemiaEnzyme InductionEtoposideCombined Modality TherapyDoxorubicinPrednisoloneBone Marrow TransplantationDrug Administration ScheduleTime FactorsSurvival AnalysisBlast CrisisDrug Therapy, CombinationAntineoplastic AgentsFollow-Up StudiesLeukocyte CountSurvival RatePlatelet CountHematopoietic Stem Cell TransplantationTransplantation, HomologousClinical Trials as TopicAntibodies, MonoclonalDisseminated Intravascular CoagulationDexamethasoneRetrospective StudiesInjections, SpinalProspective StudiesTransplantation, AutologousImmunosuppressive AgentsNephrotic SyndromeMesalamineAge FactorsColitis, UlcerativeAntirheumatic AgentsAntibodies, Monoclonal, Murine-DerivedRNA, MessengerCrohn DiseaseLymphoma, Non-HodgkinSalvage TherapySeverity of Illness IndexArthritis, RheumatoidInduction ChemotherapyHodgkin DiseaseCells, CulturedDose-Response Relationship, DrugDepressive Disorder, MajorLeukemia, Myelogenous, Chronic, BCR-ABL PositiveWegener GranulomatosisPituitary ACTH HypersecretionApoptosisEmbryonic InductionMelphalanGlucocorticoidsCladribineTransplantation ConditioningBleomycinVidarabineAminosalicylic AcidsGene Expression RegulationProcarbazineSignal TransductionGastrointestinal AgentsAnti-Inflammatory AgentsGraft vs Host DiseaseCell LineDisease ProgressionAzathioprineGlomerulonephritis, MembranousWhole-Body IrradiationMechlorethamineActuarial AnalysisLymphoma, FollicularMolecular Sequence DataMultiple MyelomaOxidesCyclosporine